Lentiviral delivery of beclin-1 in AD, PD, and SCA3 mouse models results in removal of amyloid β (Aβ), α-synuclein, and ataxin-3 aggregates, respectively [16], [31], [32]. Here, ATXN3 is linked to Parkinson disease.